Oncolytics Biotech Inc - Company Profile
Powered by 
All the sales intelligence you need on Oncolytics Biotech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Oncolytics Biotech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Oncolytics Biotech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Oncolytics Biotech Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Oncolytics Biotech Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Wayne Pisano
Chairman Executive BoardMr. Wayne Pisano has been the Chairman of the company since 2025. Previously, he served as the President and the Chief Executive Officer of VaxInnate. Prior to this, he served as the President and the Chief Executive Officer of Sanofi Pasteur from 2007 to 2011. Earlier, Mr. Pisano served various leadership roles at Novartis.
Jared Kelly
Chief Executive Officer; Director Executive BoardMr. Jared Kelly has been the Chief Executive Officer and Director of the company since 2025. Previously, he served as Head of Legal and Corporate Strategy at Ambrx. Earlier, Mr. Kelly served as a lawyer for Kirkland & Ellis LLP and a partner at Lowenstein Sandler LLP.
Kirk Look
Chief Financial Officer Senior ManagementMr. Kirk Look has been the Chief Financial Officer of the company since 2012. Previously, he served as the company's Controller of the company from 2003 to 2012. Prior to this, he served as the Manager of Audit and Assurance Services at Ernst & Young LLP in Canada from 2000 to 2003. Earlier, Mr. Look served as an Audit Manager and Senior Accountant at Ernst & Young LLP in Chile from 1998 to 1999.
John McAdory
Chief Operating Officer Senior ManagementMr. John McAdory has been the Chief Operating Officer of the company since June 2026. Previously, he served as Vice President of Clinical Operations at CG Oncology.
Allison Hagerman
Vice President - Product Development; Chief Technology Officer Senior ManagementMs. Allison Hagerman has been the Chief Technology Officer and the Vice President of Product Development of the company since 2017. Previously, she served as a Director of Manufacturing and Engineering of the company from 2013 to 2017. Prior to this, she served as a Project Manager of the company from 2010 to 2013.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer